Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-14-002899
Filing Date
2014-09-08
Accepted
2014-09-08 20:08:54
Documents
1
Period of Report
2014-09-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4.html 4  
1 OWNERSHIP DOCUMENT form4.xml 4 3605
  Complete submission text file 0001493152-14-002899.txt   5196
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address
Nelson William H. (Reporting) CIK: 0001618841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 141092114